Related Experiment Videos
Hypercholesterolemia. The evidence supports use of statins
1Department of Medicine, Divisions of Cardiology and Geriatrics, New York Medical College, Valhalla, NY, USA.
Insights
Statins significantly reduce mortality and cardiovascular events in older adults with coronary artery disease and high cholesterol. These lipid-lowering drugs are recommended for high-risk individuals, regardless of age or baseline lipid levels.
Area of Science:
- Cardiology
- Pharmacology
- Geriatrics
Background:
- Coronary artery disease (CAD) and hypercholesterolemia are significant health concerns in older populations.
- Effective management strategies are crucial to reduce morbidity and mortality.
Purpose of the Study:
- To evaluate the efficacy of statin therapy in older adults with established cardiovascular disease.
- To determine the role of statins in primary prevention for older individuals at high risk for vascular events.
Main Methods:
- Review of clinical trial data, including the Heart Protection Study.
- Analysis of outcomes such as all-cause mortality, cardiovascular mortality, and specific cardiovascular events.
- Assessment of lipid-lowering targets and treatment indications for statins.
Main Results:
- Statins reduce all-cause mortality, cardiovascular mortality, coronary events, stroke, and heart failure in older adults with CAD and hypercholesterolemia.
- Target low-density lipoprotein (LDL) cholesterol < 100 mg/dL is recommended for older patients with multiple vascular risk factors.
- Statins are effective in preventing cardiovascular events in older individuals with hypercholesterolemia, even without prior cardiovascular disease.
Conclusions:
- Statin therapy is beneficial for older men and women with CAD and hypercholesterolemia.
- Consider statins for older individuals with elevated LDL cholesterol (> or = 130 mg/dL) or low HDL cholesterol (< 50 mg/dL) without existing cardiovascular disease.
- Treating high-risk patients with statins is recommended irrespective of age or baseline lipid levels, as supported by the Heart Protection Study.
Abstract:
Using statins to treat older men and women with coronary artery disease (CAD) and hypercholesterolemia reduces the risk of all-cause mortality, cardiovascular mortality, coronary events, coronary revascularization, stroke, Intermittent claudication, and congestive heart failure. The target serum low-density lipoprotein (LDL) cholesterol level is < 100 mg in older patients with CAD, prior stroke, peripheral arterial disease, extracranial carotid arterial disease, abdominal aortic aneurysm, diabetes meilitus, and the metabolic syndrome. Statins are also effective in reducing cardiovascular events in older persons with hypercholesterolemia without cardiovascular disease. Consider using statins in older persons without cardiovascular disease but with a serum LDL cholesterol > or = 130 mg/dL, or a serum high-density lipoprotein cholesterol < 50 mg/dL. Data from the Heart Protection Study favor treating patients at high risk for vascular events with statins regardless of age or initial serum lipids.